kld, you are correct ... more was expected. There is only one slide that shows any new trial data and that is #29 with the "Strong Responders," of which, one (#101013) has declined on both measurements since Week 57.
The slides on 2-73 concentration (#23 and $24) measure through Part B, nothing for the new trial.
Hopefully, this is not the road show presentation as it seems to lack any energy to excite an investor.